Neoantigen Peptide Vaccine Strategy in Pancreatic Cancer Patients Following Surgical Resection and Adjuvant Chemotherapy
Clinical trial NCT03956056 · TERMINATED
Trial details
- NCT number
- NCT03956056
- Sponsor
- Washington University School of Medicine
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-13
- Primary completion
- 2022-07-21
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.